Whether it’s a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.
Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) shares closed up 8.86 percent on Monday with over 101 million shares traded. The stock had one of the biggest volume jumps on the NASDAQ. The big move came after Chardan Capital upgraded the biotech from neutral to buy. Analyst Ling Wang planted a price target of $9 on the stock.
Get more information on Ariad Pharmaceuticals Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/ARIA
Meritor, Inc. (NYSE: MTOR) shares closed up 18.14 percent on Monday with about 8.1 million shares traded. The stock was one of the biggest gainers on the NYSE and hit a new 52-week high of $9.27 during intra-day trading. The big move came after a note from Morgan Stanley indicated that Meritor received a somewhat favorable ruling in a Delaware District Court today with Eaton‘s request for a pre-trial motion of judgment being denied.
Get more information on Meritor, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/MTOR
22nd Century Group, Inc. (OTCBB: XXII) shares closed down 3.19 percent on Monday with about 700,000 shares traded. The stock was one of the most active stocks in the OTBB market and hit a new 52-week high of $2.01 during intra-day trading. The company announced a warrant exchange this month that reduced 22nd Century Group’s “derivative warrant liability” by 93 percent and generated gross proceeds of approximately $3.6 million for the Company.
Get more information on 22nd Century Group, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/XXII
TechPrecision Corporation (OTC: TPCS) shares closed up 16.48 percent on Monday with nearly 2.9 million shares traded. The stock was one of the biggest gainers in the OTC market. TechPrecision Corporation, an industry leading global manufacturer of precision, large-scale fabricated and machined metal components and tested systems with customers in the naval/maritime, energy and precision industrial sectors, congratulated Mevion Medical Systems on the milestone event of delivering the world’s first MEVION S250 Proton Therapy System for treatment at the S. Lee Kling Proton Therapy Center at Barnes-Jewish Hospital in St. Louis. A patient with a rare type of cancer called chondrosarcoma at the base of the skull has become the first person in the world to receive proton therapy using the system.
Get more information on TechPrecision Corporation and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/TPCS
Disclosure: TrendingWallStreet.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.